Showing results (161-170 of 3,769) with videos related to

Sort By:
Pageof 377
Oncoimmunology|April 9, 2016
Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg)F Figueiró, L Muller, S Funk, et al.
The Journal of Clinical Investigation|October 1, 1986
Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension in ratsA Ohnishi, R A Branch, K Jackson, et al.
Kidney International|June 2, 1998
Perfusion quantitation in transplanted rat kidney by MRI with arterial spin labelingJ J Wang, K S Hendrich, E K Jackson, et al.
American Heart Journal|August 1, 1985
Effects of indomethacin on systemic and coronary hemodynamics in patients with coronary artery diseaseM B Forman, H Uderman, E K Jackson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2000
Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activityR K Dubey, E K Jackson, D G Gillespie, et al.
Research Communications in Molecular Pathology and Pharmacology|July 2, 2002
Liposomal atp or NAD+ protects human endothelial cells from energy failure in a cell culture model of sepsisY Y Han, L Huang, E K Jackson, et al.
Cardiovascular Research|January 1, 1993
Intravenous adenosine suppresses cardiac release of endothelin after myocardial ischaemia and reperfusionC E Velasco, E K Jackson, J A Morrow, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1981
6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogueE K Jackson, W A Herzer, J B Zimmerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2000
Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: possible role of the neutrophil chemoattractant responseM B Forman, J V Vitola, C E Velasco, et al.
Pageof 377